Physician profile
Ali Alavi
NPI 1508936592
$10,728.43
in general payments reported to CMS, 2019-2025
42 companies · $2,522 in 2025
The $2,522 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,381 · 2020: $1,006 · 2021: $1,892 · 2022: $1,243 · 2023: $568 · 2024: $1,116 · 2025: $2,522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,109 · Education: $98.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,108.57 |
| Education | $98.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,693.90 | 2019-2020 | |
| Abbvie INC. | $1,266.92 | 2019-2025 | Botox, Lupron Depot |
| Boston Scientific Corporation | $1,213.75 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System, Ams 700 |
| Teleflex LLC | $1,051.84 | 2021-2025 | Urolift, Barrigel, Solesta |
| Medtronic, INC. | $837.50 | 2021-2025 | Interstim, Altaviva |
| Astellas Pharma US INC | $772.67 | 2019-2025 | Xtandi |
| Coloplast Corp | $761.04 | 2020-2025 | |
| Allergan, INC. | $404.17 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $334.24 | 2023-2025 | Gemtesa, Orgovyx |
| Urogen Pharma, INC. | $333.09 | 2022-2025 | Jelmyto |
| Janssen Biotech, INC. | $330.36 | 2019-2025 | Erleada |
| Pfizer INC. | $251.69 | 2019-2025 | |
| Procept Biorobotics Corporation | $225.48 | 2022-2025 | Aquabeam System |
| Myovant Sciences INC. | $143.83 | 2021-2022 | |
| Blue Earth Diagnostics | $116.14 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Alavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.